Relay Therapeutics, Inc. logo RLAY - Relay Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 14
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $23.00 DETAILS
HIGH: $27.00
LOW: $18.00
MEDIAN: $22.00
CONSENSUS: $23.00
UPSIDE: 69.99%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Revenue
Revenue 3 7 0 0.7 7.7 0 0 0 10.0 (0.0) 25.2 0.1 0.2 0.3 0.3 0.4 0.4 0.6 0.7 0.8 1.0 82.7 0 0 0 0 0 0 0
Cost of Revenue 0.5 0.6 0 0 0 0 0 0 0 0 81.5 88.2 82.8 63.9 66.9 60.5 51.7 51.1 44.2 45.1 30.6 0.9 0 0 0 0 0 0 0
Gross Profit 2.5 6.4 0 0.7 7.7 0 0 0 10.0 (0.0) (56.3) (88.1) (82.6) (63.7) (66.6) (60.1) (51.2) (50.5) (43.5) (44.3) (29.7) 81.7 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 70.6 55.4 68.3 63.9 73.8 68.1 76.6 92.0 82.4 77.5 81.5 88.2 82.8 67.3 66.9 60.5 51.7 51.9 45.0 168.1 30.6 31.4 24.4 21.7 21.7 22.4 18.3 16.4 13.3
SG&A Expenses 11.0 13.0 12.1 13.6 18.7 16.9 19.8 20.1 19.8 16.8 18.5 20.1 19.6 19.7 16.1 17.5 16.1 15.5 15.5 14.4 12.7 15.3 12.2 6.1 4.8 3.4 3.7 3.5 3.1
Other Expenses (0.5) (1.3) 0 0 0 0 0 (11.4) (1.8) (2.1) (82.7) (90.4) (83.8) (77.8) (63.6) (60.3) (56.3) (50.2) (43.0) (33.3) (30.6) 0 0 0 0 0 (0.0) 0 (0.1)
Operating Expenses 81.1 67.0 80.4 77.5 92.5 85.0 96.4 100.8 100.4 92.2 17.3 18.0 18.6 9.2 19.3 17.7 11.5 17.2 17.5 149.3 12.7 46.8 36.6 27.7 26.5 25.8 21.9 19.9 16.4
Operating Income
Operating Income (78.6) (60.6) (80.4) (76.8) (84.9) (85.0) (96.4) (100.8) (90.4) (92.2) (73.6) (106.0) (101.2) (72.9) (85.9) (77.8) (62.7) (67.7) (61.0) (193.6) (42.4) 35.0 (36.6) (27.7) (26.5) (25.8) (21.9) (19.9) (16.4)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 5.4 5.7 6.4 7.1 7.8 9.0 8.3 8.5 9.0 8.7 7.8 7.6 6.9 5.4 1.7 1.0 0.7 0.3 0.2 0.2 0.2 0.3 0.5 1.0 1.6 1.9 2.2 2.4 2.3
Profitability
EBITDA (78.1) (57.8) (79.6) (75.8) (83.7) (83.6) (95.0) (110.8) (90.8) (92.9) (73.4) (106.9) (101.0) (82.2) (81.6) (76.7) (66.3) (65.0) (58.0) (57.8) (41.5) 36.2 (35.7) (26.9) (25.6) (25.0) (21.3) (19.2) (15.7)
EBIT (78.6) (54.9) (80.4) (76.8) (84.9) (85.0) (96.4) (112.1) (92.2) (94.3) (74.8) (108.2) (102.2) (83.4) (82.6) (77.6) (67.3) (66.0) (59.0) (58.7) (42.4) 35.3 (36.6) (27.7) (26.5) (25.8) (21.9) (19.9) (16.4)
Income Before Tax (73.3) (54.9) (74.1) (70.4) (77.1) (76.0) (88.1) (92.2) (81.4) (83.5) (65.7) (98.5) (94.2) (67.5) (84.2) (76.8) (62.0) (67.5) (60.8) (193.4) (42.2) 35.3 (36.1) (26.7) (24.9) (23.9) (19.7) (17.5) (14.2)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (73.3) (54.9) (74.1) (70.4) (77.1) (76.0) (88.1) (92.2) (81.4) (83.5) (65.7) (98.5) (94.2) (67.5) (84.2) (76.8) (62.0) (67.5) (60.8) (193.4) (42.2) 35.3 (36.1) (26.7) (24.9) (23.9) (19.7) (17.5) (14.2)
Per Share Data
EPS (Basic) -0.41 -0.32 -0.43 -0.41 -0.46 -0.45 -0.63 -0.69 -0.62 -0.68 -0.54 -0.81 -0.72 -0.36 -0.79 -0.71 -0.48 -0.66 -0.66 -2.10 -0.47 0.50 -0.51 -6.06 -5.99 -6.24 -5.53 -5.28 -4.59
EPS (Diluted) -0.41 -0.32 -0.43 -0.41 -0.46 -0.45 -0.63 -0.69 -0.62 -0.68 -0.54 -0.81 -0.72 -0.36 -0.79 -0.71 -0.48 -0.66 -0.66 -2.10 -0.47 0.50 -0.51 -6.06 -5.99 -6.24 -5.53 -5.28 -4.59
Shares Outstanding 179.8 171.6 172.4 171.3 169.2 167.3 140.2 132.8 130.8 122.6 122.2 121.7 121.3 121.0 110.9 108.6 108.3 102.7 92.7 91.9 90.2 89.9 71.2 4.4 4.2 3.8 3.6 3.3 3.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q1
Current Assets
Cash & Cash Equivalents 204.6 84.0 91.6 113.9 93.5 124.3 152.4 134.1 152.9 143.7 151.3 145.9 161.3 998.9 354.6 107.7 119.4 280.1 228.6 260.1 262.7 447.6 559.3 137.1 70.3 42.0 (421.5)
Short-Term Investments 437.5 470.5 504.9 542.8 616.8 657.0 687.3 554.3 596.7 606.4 659.3 725.7 776.5 0 699.1 730.3 778.7 678.0 387.9 411.2 463.4 230.4 154.2 175.2 263.9 313.9 843.0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0.2 0.1 5.2 5.2 5.1 5.1 4.9 4.9 5.1 4.5 8.6 82.7 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 11.3 12.1 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 4.6 23.8 3.7 7.6 7.4 10.5 6.8 5.7 7.3 3.3 3.7 3.4 4.1 3.3 11.6 0 0 1.8 0 0 0 0 0 0 0 0 0
Total Current Assets 658.5 578.3 624.0 680.4 739.7 809.2 865.1 704.3 770.1 770.1 831.8 884.3 958.4 1,019.5 1,087.3 855.8 915.8 976.2 639.3 681.3 742.4 770.1 721.9 315.9 338.7 360.5 421.5
Non-Current Assets
Property, Plant & Equipment 39.8 41.7 43.7 46.2 55.3 57.7 60.6 63.3 66.3 68.9 70.2 72.7 74.3 75.4 76.5 28.8 29.2 27.3 27.5 28.2 28.0 28.8 29.0 30.2 30.7 31.7 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 2.3 0 0 0 0 0 0 0
Long-Term Investments 1.3 1.3 0 0 0 0 2.1 2.7 0 0 0 0 2.6 2.6 0 2.6 0 2.6 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0 0 2.3 2.3 2.1 2.1 0 2.7 2.7 2.7 2.7 2.7 2.6 2.6 2.6 2.6 2.6 2.6 2.6 2.6 0.9 0.9 0.9 2.0 0.9 0.9 (421.5)
Total Non-Current Assets 41.2 43.1 46.0 48.4 59.7 62.1 65.0 68.3 71.3 73.9 75.2 77.7 79.2 80.3 81.4 33.6 34.1 32.2 32.4 33.1 28.9 29.7 29.8 32.2 31.6 32.5 (421.5)
Total Assets 699.6 621.3 670 728.8 799.4 871.3 930.1 772.5 841.4 844.0 907.0 962.0 1,037.6 1,099.8 1,168.7 889.4 949.9 1,008.4 671.6 714.4 771.3 799.8 751.7 348.0 370.3 393.1 0
Current Liabilities
Account Payables 4.1 7.7 2.8 5.2 8.4 14.1 6.9 11.2 8.0 9.2 13.4 14.8 11.8 10.6 9.5 4.3 8.1 8.3 6.3 7.9 5.6 6.4 4.6 2.8 4.0 7.0 0
Short-Term Debt 3.9 3.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 7.7 0 0 0 0 0 0 0 0 0 0.1 0.2 0.2 0 0 0 0 0 0 0 0 0
Other Current Liabilities 21.8 14.1 1.1 0.6 1.7 2.1 1.4 0.8 1.7 1.2 1.1 25.3 26.1 26.2 26.9 15.4 16.3 1.0 0.3 0.4 0 0.2 0 0 0.2 0.3 0
Total Current Liabilities 29.8 25.6 32.6 32.5 37.1 50.7 47.0 45.0 37.1 30.3 50.7 71.6 70.5 63.7 71.4 43.9 41.7 24.3 28.5 25.4 16.1 13.6 15.7 12.8 11.5 12.0 0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 11.4 13.2 28.0 29.2 31.4 32.4 42.9 45.9 45.7 65.3 50.5 48.5 0 0.0 0.0 537.8 0.1 537.9 0
Total Non-Current Liabilities 27.7 28.7 29.7 30.7 41.2 42.8 44.3 45.8 58.5 61.7 77.8 80.3 83.7 85.8 97.5 65.9 66.2 86.3 72.0 70.5 22.5 22.9 22.5 560.7 23.3 561.5 0
Total Liabilities 57.4 54.3 62.3 63.2 78.3 93.5 91.3 90.8 95.7 92.0 128.6 151.9 154.1 149.6 168.9 109.8 107.9 110.6 100.5 95.9 38.6 36.5 38.2 573.4 34.8 573.5 0
Stockholders' Equity
Common Stock 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0
Retained Earnings (2,088.1) (2,014.8) (1,959.9) (1,885.7) (1,815.4) (1,738.3) (1,662.3) (1,574.2) (1,482.0) (1,400.6) (1,317.1) (1,251.4) (1,152.8) (1,058.6) (991.1) (906.9) (830.1) (768.1) (700.6) (639.8) (446.4) (404.2) (439.5) (241.1) (214.4) (189.5) 0
Accumulated Other Comprehensive Income (0.2) 0.7 0.5 (0.2) 0.0 (1.0) 2.5 (1.3) (1.2) (0.2) (3.4) (6.1) (5.8) (10.4) (13.4) (11.9) (9.2) (1.1) 0.0 (0.1) 0.0 0.1 0.2 0.6 1.4 0.3 (110.9)
Total Stockholders' Equity 642.2 567.1 607.7 665.7 721.1 777.8 838.9 681.7 745.8 752.0 778.4 810.1 883.4 950.2 999.8 779.6 842.0 897.8 571.1 618.5 732.8 763.3 713.5 (225.4) 335.4 (180.4) 421.2
Total Liabilities & Equity 699.6 621.3 670 728.8 799.4 871.3 930.1 772.5 841.4 844.0 907.0 962.0 1,037.6 1,099.8 1,168.7 889.4 949.9 1,008.4 671.6 714.4 771.3 799.8 751.7 348.0 370.3 393.1 421.2
Debt Metrics
Total Debt 31.6 32.5 33.3 34.2 47.2 48.5 49.8 51.1 52.3 53.5 54.6 55.7 56.7 57.7 60.3 22.0 22.5 22.9 23.3 23.7 24.1 24.4 23.9 24.2 24.6 24.8 0
Net Debt (173.0) (51.6) (58.2) (79.8) (46.4) (75.8) (102.5) (83.0) (100.6) (90.3) (96.7) (90.2) (104.5) (941.2) (294.4) (85.7) (97.0) (257.2) (205.2) (236.4) (238.6) (423.2) (535.4) (112.8) (45.8) (17.1) 421.5
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Operating Activities
Net Income (73.3) (54.9) (74.1) (70.4) (77.1) (76.0) (88.1) (92.2) (81.4) (83.5) (65.7) (98.5) (94.2) (67.5) (84.2) (76.8) (62.0) (67.5) (60.8) (193.4) (42.2) 35.3 (36.1) (26.7) (24.9) (23.9) (19.7) (17.5) (14.2)
Depreciation & Amortization (0.3) (0.3) 0.7 (0.4) (0.4) 1.3 (8.8) 1.4 1.4 1.4 1.4 1.3 1.2 1.2 1.0 1.0 1.0 1.0 1.0 1.0 0.9 0.9 0.9 0.9 0.9 0.9 0.6 0.7 0.7
Stock-Based Compensation 10.5 13.1 15.5 14.5 19.3 17.6 22.5 26.8 27.2 19.3 21.8 23.4 21.5 13.8 13.7 15.1 13.5 10.2 12.4 16.1 9.7 14.5 11.9 4.0 1.5 1.3 1.2 1.1 0.8
Change in Working Capital 11.9 (2.8) (3.5) (1.9) (15.1) 1.4 (20.8) 12.8 8.0 (20.6) (28.8) 9.5 7.4 6.4 (0.3) 2.8 2.4 15.0 (8.5) 12.7 78.1 (86.0) (0.8) 1.1 0.6 (0.4) 1.4 1.4 1.8
Other Non-Cash Items 0 0.0 (0.7) 2.9 0 (2.3) 20.1 (14.7) (5.5) (10.8) (1.2) (4.4) (3.0) (10.9) 3.6 0.7 (3.9) 1.5 2.7 135.4 0.2 0.0 0.0 (0.1) (0.3) (0.6) (1.1) (0.7) 0.1
Operating Cash Flow (51.1) (44.9) (62.1) (55.3) (73.2) (57.9) (75.1) (65.8) (50.3) (89.2) (75.4) (68.6) (67.1) (57.1) (66.1) (57.1) (49.2) (39.7) (53.2) (28.1) 46.6 (35.3) (24.0) (20.8) (22.3) (22.8) (17.5) (15.1) (10.8)
Investing Activities
Capital Expenditure 0 (0.0) 0.0 (0.0) (0.4) 0 (0.2) (0.0) (1.8) (0.1) (0.6) (1.5) (1.9) (2.3) (2.1) (1.9) (2.8) (0.9) (1.7) (0.4) (0.5) (0.1) (0.4) (0.4) (1.0) (0.6) (2.4) (1.9) (3.1)
Acquisitions 0 0 0 0 0 0 0 0 0 (257.6) (72.0) 0 0 0 0 0 0 (0.1) (0.1) 0 0 0 0 0 0 0 0 0 0
Purchases of Investments (50.9) (34.0) (58.1) (8.9) (22.0) (75.1) (265.1) (119.6) (190.8) (136.8) (84.8) (66.2) (97.8) (327.6) (55.8) (24.3) (127.7) (327.0) (7.4) (26.9) (619.3) (126.4) (69.0) (15.5) (55.6) (89.0) (89.5) (375) 0
Sales/Maturities of Investments 83.8 69.5 97.8 84.1 64.8 104.1 139.2 165.2 203.1 196.6 156.7 118.9 175.0 183.0 85.1 69.5 18.1 35.2 30 78.5 386.2 50.0 89.5 103.6 107 125.5 99 18 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 257.6 72.0 0 0 0 0 0 0 0 0 (25.1) 0 0 0 0 0 0 9.5 0.0 0
Investing Cash Flow 32.9 35.5 39.7 75.1 42.5 29.0 (126.2) 45.5 10.5 59.7 71.4 51.3 75.3 (146.9) 27.2 43.4 (112.4) (292.7) 20.8 26.1 (233.6) (76.4) 20.1 87.6 50.4 35.9 7.1 (358.9) (3.1)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0 0 0 0 0.7 0 1.2 1 0.1 0 0 0 285.9 0 0 1.8 0 0 0 (425.3) (2.0) (0.5) 0 0 0 0.7 0
Financing Cash Flow 138.8 0.9 0.0 0.7 0 0.8 218.9 1.5 48.9 21.9 9.5 2.1 1.3 1.2 285.9 2.0 0.9 384.0 0.9 1.1 2.1 0.1 426.2 (0.1) 0.4 (0.2) 0.1 0.7 5.0
Cash Position
Net Change in Cash 120.6 (8.5) (22.4) 20.5 (30.7) (28.1) 17.6 (18.7) 9.1 (7.6) 5.4 (15.4) 9.5 (202.8) 246.9 (11.7) (160.7) 51.6 (31.5) (1.0) (184.9) (111.6) 422.2 66.7 28.4 12.9 (10.3) (373.2) (8.9)
Cash at Beginning 85.4 93.8 113.9 95.7 126.4 152.4 136.8 152.9 146.4 154.0 148.6 161.3 151.8 354.6 110.3 119.4 280.1 231.1 262.6 263.6 448.5 559.3 137.9 71.2 42.8 29.9 40.2 413.5 422.4
Cash at End 205.9 85.4 91.6 116.2 95.7 124.3 154.5 134.1 155.6 146.4 154.0 145.9 161.3 151.8 357.2 107.7 119.4 282.7 231.1 262.6 263.6 447.6 560.2 137.9 71.2 42.8 29.9 40.2 413.5
Free Cash Flow (51.1) (44.9) (62.1) (55.3) (73.6) (57.9) (75.3) (65.8) (52.1) (89.3) (76.0) (70.1) (69.0) (59.4) (68.2) (59.0) (52.0) (40.6) (54.9) (28.5) 46.2 (35.3) (24.5) (21.3) (23.4) (23.4) (19.9) (16.9) (14.0)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1
Income Statement
Revenue 3 7 0 0.7 7.7 0 0 0 10.0 (0.0) 25.2 0.1 0.2 0.3 0.3 0.4 0.4 0.6 0.7 0.8 1.0 82.7 0 0 0 0 0 0 0
Gross Profit 2.5 6.4 0 0.7 7.7 0 0 0 10.0 (0.0) (56.3) (88.1) (82.6) (63.7) (66.6) (60.1) (51.2) (50.5) (43.5) (44.3) (29.7) 81.7 0 0 0 0 0 0 0
Operating Income (78.6) (60.6) (80.4) (76.8) (84.9) (85.0) (96.4) (100.8) (90.4) (92.2) (73.6) (106.0) (101.2) (72.9) (85.9) (77.8) (62.7) (67.7) (61.0) (193.6) (42.4) 35.0 (36.6) (27.7) (26.5) (25.8) (21.9) (19.9) (16.4)
Net Income (73.3) (54.9) (74.1) (70.4) (77.1) (76.0) (88.1) (92.2) (81.4) (83.5) (65.7) (98.5) (94.2) (67.5) (84.2) (76.8) (62.0) (67.5) (60.8) (193.4) (42.2) 35.3 (36.1) (26.7) (24.9) (23.9) (19.7) (17.5) (14.2)
EPS (Diluted) -0.41 -0.32 -0.43 -0.41 -0.46 -0.45 -0.63 -0.69 -0.62 -0.68 -0.54 -0.81 -0.72 -0.36 -0.79 -0.71 -0.48 -0.66 -0.66 -2.10 -0.47 0.50 -0.51 -6.06 -5.99 -6.24 -5.53 -5.28 -4.59
Balance Sheet
Cash & Equivalents 204.6 84.0 91.6 113.9 93.5 124.3 152.4 134.1 152.9 143.7 151.3 145.9 161.3 998.9 354.6 107.7 119.4 280.1 228.6 260.1 262.7 447.6 559.3 137.1 70.3 42.0 (421.5)
Total Assets 699.6 621.3 670 728.8 799.4 871.3 930.1 772.5 841.4 844.0 907.0 962.0 1,037.6 1,099.8 1,168.7 889.4 949.9 1,008.4 671.6 714.4 771.3 799.8 751.7 348.0 370.3 393.1 0
Total Debt 31.6 32.5 33.3 34.2 47.2 48.5 49.8 51.1 52.3 53.5 54.6 55.7 56.7 57.7 60.3 22.0 22.5 22.9 23.3 23.7 24.1 24.4 23.9 24.2 24.6 24.8 0
Stockholders' Equity 642.2 567.1 607.7 665.7 721.1 777.8 838.9 681.7 745.8 752.0 778.4 810.1 883.4 950.2 999.8 779.6 842.0 897.8 571.1 618.5 732.8 763.3 713.5 (225.4) 335.4 (180.4) 421.2
Cash Flow
Operating Cash Flow (51.1) (44.9) (62.1) (55.3) (73.2) (57.9) (75.1) (65.8) (50.3) (89.2) (75.4) (68.6) (67.1) (57.1) (66.1) (57.1) (49.2) (39.7) (53.2) (28.1) 46.6 (35.3) (24.0) (20.8) (22.3) (22.8) (17.5) (15.1) (10.8)
Capital Expenditure 0 (0.0) 0.0 (0.0) (0.4) 0 (0.2) (0.0) (1.8) (0.1) (0.6) (1.5) (1.9) (2.3) (2.1) (1.9) (2.8) (0.9) (1.7) (0.4) (0.5) (0.1) (0.4) (0.4) (1.0) (0.6) (2.4) (1.9) (3.1)
Free Cash Flow (51.1) (44.9) (62.1) (55.3) (73.6) (57.9) (75.3) (65.8) (52.1) (89.3) (76.0) (70.1) (69.0) (59.4) (68.2) (59.0) (52.0) (40.6) (54.9) (28.5) 46.2 (35.3) (24.5) (21.3) (23.4) (23.4) (19.9) (16.9) (14.0)